In this regard, cord blood CD34+ cells have been used to generate anti-HIV iPSCs, which carried CCR5 shRNA in combination with a chimeric human/rhesus TRIM5α molecule [105], which was demonstrated to be a potent pre-integration inhibitor of HIV-1 infection [106]. This evidence concerns the gene CCR5 and HIV-1 infection.